26th week of 2013 patent applcation highlights part 54 |
Patent application number | Title | Published |
20130165483 | HETEROARYLS AND USES THEREOF - This invention provides compounds of formula IB: | 2013-06-27 |
20130165484 | Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients - A capsule formulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. In one embodiment, this capsule formulation is capable of sustaining desirable pharmacokinetic responses in a patient. Further provided are methods of treating fibrotic conditions and other cytokine-mediated disorders by administering pirfenidone capsules of such formulation to a patient in need. | 2013-06-27 |
20130165485 | INSECTICIDAL COMPOUNDS - A compound of formula (I): | 2013-06-27 |
20130165486 | TETRASUBSTITUTED BENZENES - Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described. | 2013-06-27 |
20130165487 | Seed Treatment Formulations - The present invention generally relates to aqueous seed treatment formulations comprising from about 0.2 to about 15% of at least one pesticidal agent, from about 0.1 to about 0.45% of at least one graft copolymer, at least one polyvinyl alcohol (PVA), and from about 5 to about 30% of at least one plasticizer. The present invention also relates to aqueous seed treatment formulations wherein the pesticidal agents are clothianidin, metconazole, and metalaxyl. | 2013-06-27 |
20130165488 | Novel Thromboxane A2 (TP) Receptor Antagonists - The present invention relates to novel TP receptor antagonists, which optionally cross the blood-brain barrier of a mammal. The invention also provides methods for treating a disorder related to activation of TP receptor utilizing the compounds of the invention. | 2013-06-27 |
20130165489 | Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof - The present invention includes a method of inhibiting, suppressing or preventing a viral infection in a subject, comprising administering to the subject a pharmaceutical composition comprising one or more of the compounds useful within the invention. | 2013-06-27 |
20130165490 | INSECTICIDAL COMPOUNDS - A compound of formula (I): | 2013-06-27 |
20130165491 | THERAPEUTIC AGENT FOR PAIN | 2013-06-27 |
20130165492 | COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE - The present invention provides a compound, that is | 2013-06-27 |
20130165493 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 2013-06-27 |
20130165494 | 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors - 1,5-diaryl-2-alkylpyrrole-3-substituted nitro esters, of Formula (I) | 2013-06-27 |
20130165495 | NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS - A method of inhibiting excitotoxicity by indirectly activating α4β2 nicotinic acetylcholine receptors (nAChRs) which indirectly activate synaptic AMPA and NMDA receptors is disclosed Inhibitors of α7 nACHRs, such as macrocyclic diterpenoids, more specifically cembranoids or methyllycaconitine (MLA), indirectly activate α4β2 nAChRs and can be used to treat neurodegenerative diseases, including, but not limited to, Alzheimer's Disease, Parkinson Disease, AIDS related dementia and the delayed effects of stroke. They can also be used to treat diseases associated with neuronal impairment, including, but not limited to glaucoma caused by optical nerve damage, delayed effects of epilepsy; and multiple sclerosis. | 2013-06-27 |
20130165496 | COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCCR - The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing. | 2013-06-27 |
20130165497 | MONITORING OF IMMUNE SYSTEM USING PERIPHERAL BLOOD MICRO-RNA EXPRESSION PROFILE ANALYSIS AND USES THEREOF - The present invention relates to a method for monitoring the immune system of an individual, which comprises measuring, preferably by quantitative RT-PCR, the expression level of at least one microRNA (miRNA) gene product in a peripheral blood sample or in a biological fluid sample, and comparing said measured expression level with a reference level. In particular, the at least one miRNA gene product, which the method of the invention measures, is expressed by lymphocyte populations of an individual, in particular by naive CD4+T, TH1, TH2 and TH17 lymphocytes. The method of the invention is useful for the diagnosis, prognosis, prevention, control and/or the treatment of a pathological condition caused by or associated with an immune system dysfunction. Moreover, the method of the present invention is useful for monitoring, in an individual, the evolution of conditions mediated by the immune system, such as the response to a vaccination. | 2013-06-27 |
20130165498 | INVERTEBRATE MICRORNAS - This invention provides plants having resistance to invertebrate pests. More specifically, this invention discloses a non-natural transgenic plant cell expressing at least one invertebrate miRNA in planta for suppression of a target gene of an invertebrate pest or of a symbiont associated with the invertebrate pest. Also provided are recombinant DNA constructs for expression of at least one invertebrate miRNA in planta, a non-natural transgenic plant containing the non-natural transgenic plant cell of this invention, a non-natural transgenic plant grown from the non-natural transgenic plant cell of this invention, and non-natural transgenic seed produced by the non-natural transgenic plants, as well as commodity products produced from a non-natural transgenic plant cell, plant, or seed of this invention. This invention further provides a method of suppressing at least one target gene of an invertebrate pest of a plant or of a symbiont associated with the invertebrate, including providing a plant including the non-natural transgenic plant cell of this invention, wherein the invertebrate is the invertebrate pest, the recombinant DNA is transcribed in the non-natural transgenic plant cell to the recombinant miRNA precursor, and when the invertebrate pest ingests the recombinant miRNA precursor, the at least one target gene is suppressed. | 2013-06-27 |
20130165499 | Methods And Compositions For Prevention Or Treatment Of RSV Infection - Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. | 2013-06-27 |
20130165500 | RNA Interference Mediated Inhibition of Prolyl Hydroxylase Domain 2 (PHD2) Gene Expression Using Short Interfering Nucleic Acid (siNA) - The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond expressed/synthetic to the modulation of PHD2 gene expression and/or activity, and/or modulate a beta-catenin gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short inter-fering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsR-NA), micro-RNA (miRNA), and short hair-pin RNA (shRNA) molecules that are capa-ble of mediating or that mediate RNA inter-ference (RNAi) against PHD2 gene expres-sion. | 2013-06-27 |
20130165501 | Lipid Binding Nucleic Acids - The present invention is related to a nucleic acid molecule capable of binding to a lipid. | 2013-06-27 |
20130165502 | Diagnostic, Prognostic and Therapeutic Uses of miRs in Adaptive Pathways and Disease Pathways - Described herein are methods and compositions for the diagnosis, prognosis and treatment of various adaptive and/or disease pathways by examining samples containing one or more miRs therein, and by formulating therapeutic agents therefrom. | 2013-06-27 |
20130165503 | Method for Treating Ocular Neovascularization - Methods are provided for the treatment of ocular neovascularization by increasing, in an individual afflicted with ocular neovascularization, in vivo concentrations of an endostatin protein in the ocular tissues of the individual to an ocular neovascularization inhibiting effective amount, where the endostatin protein has anti-ocular neovascularization activity in vivo. | 2013-06-27 |
20130165504 | METHODS OF INCREASING THE VIABILITY OR LONGEVITY OF AN ORGAN OR ORGAN EXPLANT - The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules for their use in improving organ viability and/or longevity. | 2013-06-27 |
20130165505 | 1-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT - Administration of certain 1-phenylalkanecarboxylic acid derivatives is useful for improving Cognitive Function; treating Cognitive Impairment, in particular Mild Cognitive Impairment; and preventing and/or reducing the risk of developing Alzheimer's Disease in a cognitively normal subject. | 2013-06-27 |
20130165506 | PULEGANIC ACID INSECT REPELLENT - The present invention relates to compositions of puleganic acid, and the use thereof as a topical treatment for skin, such as a repellant for insects or arthropods. | 2013-06-27 |
20130165507 | NEW GUANIDINE DERIVATIVES IN CINNAMIC SERIES - The invention relates to novel guanidine derivatives in the cinnamic series of general formula (I): | 2013-06-27 |
20130165508 | METHODS AND FORMULATIONS FOR TREATING INEFFECTIVE OR DECREASED ESOPHAGAL MOTILITY - Disclosed embodiments describe pharmaceutical compositions and methods for treating ineffective esophageal motility in which bethanechol and pharmaceutically acceptable absorption enhancers including bile acids and mixtures thereof are topically introduced to the esophagus. Therapeutically effective amounts of bethanechol are delivered while reducing or eliminating parasympathetic nervous system side effects normally associated with systemic bethanechol delivery. | 2013-06-27 |
20130165509 | PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - A phenyl alkyl carbamate derivative compound and a pharmaceutical composition containing the compound are provided. More specifically, the phenyl alkyl carbamate derivative compound and a pharmaceutically acceptable salt thereof, a composition for muscle relaxation containing the phenyl alkyl carbamate derivative compounds and/or pharmaceutically acceptable salt thereof as an active ingredient, and a method of muscle relaxation comprising administering a pharmaceutically effective amount of the phenyl alkyl carbamate derivative compound and/or a pharmaceutically acceptable salt thereof to a subject in need of to a subject in need of, are provided. | 2013-06-27 |
20130165510 | TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USE - The invention relates to inhibitors of trypsin-like serine proteases, including those of the general formula (IV) which, as well as plasmin, also inhibit plasma kallikrein, and to their use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive. | 2013-06-27 |
20130165511 | TREATMENT FOR COCAINE ADDICTION - A novel pharmaceutical composition is provided for the control of stimulant effects, in particular treatment of cocaine addiction, or further to treatment of both cocaine and alcohol dependency, including simultaneous therapeutic dose application or a single dose of a combined therapeutically effective composition of disulfiram and selegiline compounds or pharmaceutically acceptable non-toxic salt thereof. | 2013-06-27 |
20130165512 | COMPOSITIONS COMPRISING A RETINOID AND AN NFkB-INHIBITOR AND THEIR METHODS OF USE - A composition including a retinoid, an NFκB-inhibitor, and a cosmetically-acceptable topical carrier is provided. Methods of treating the skin are also provided. | 2013-06-27 |
20130165513 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME - The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases. | 2013-06-27 |
20130165514 | ORALLY ADMINISTERED COMPOSITION AND DIETARY COMPOSITION HAVING SERUM LIPID IMPROVING EFFECT - The present invention provides an orally administered composition and a dietary composition, which have a serum lipid improving effect. The orally administered composition and dietary composition, having a serum lipid improving effect, according to the present invention camp rise 2.0% by weight or less of a DHA ethyl ester composition comprising 75% by weight or more of DHA ethyl ester. It is preferable to comprise 1.2% by weight or less of the DHA ethyl ester composition. It is preferable not to substantially comprise a DHA ethyl ester composition comprising 30% by weight or less of DHA ethyl ester. | 2013-06-27 |
20130165515 | Organosulfur Compounds for the Prevention and Treatment of Neurodegenerative Diseases - Divalent salts of S-allylmercapto-N-acetylcysteine and related compositions are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein carbonylation, protein aggregation, and the resulting neuroinflammation. Various neurodegenerative diseases which are suitable for treatment using these compositions include Alzheimer's disease, senile dementia, Parkinson's disease, multiple sclerosis, Lewy body disease, peripheral neuropathy, spinal cord injury, stroke and cerebral ischemia. | 2013-06-27 |
20130165516 | Acetylcysteine Composition and Uses Thereof - This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA. Further, this invention relates to methods of making and using the acetylcysteine compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time maintaining the stability of the pharmaceutical formulation. The compositions and methods of this invention are useful in the treatment of acetaminophen overdose, acute liver failure, various cancers, methacrylonitrile poisoning, reperfusion injury during cardio bypass surgery, and radiocontrast-induced nephropathy, and can also be used as a mucolytic agent. | 2013-06-27 |
20130165517 | Composition and Method for Treating Neurological Disease - A method of treating a patient with Parkinson's disease is provided. The method comprises orally administering to the patient a first agent comprising levodopa and once-daily, orally administering to the patient a second agent comprising amantadine, or a pharmaceutically acceptable salt thereof. The amount of levodopa administered is reduced by 20% to 80% of the amount required in the absence of amantadine. | 2013-06-27 |
20130165519 | Method of Bowel Cleansing - A method is disclosed for cleansing bowels prior to a colonic procedure utilizing conventional preparations along with potatoes or potato-constituents or potato-substitutes. | 2013-06-27 |
20130165520 | Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties - Hybrid molecules comprising a retinoic acid receptor agonist moiety and a histone deacetylase inhibitor (HDAC) moiety are disclosed. Hybrid molecule 3 (6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)naphthalene-2-hydroxamic acid) was proven to posses HDAC activity while maintaining RAR agonist activity. Hybrid molecule 3 and pharmaceutical compositions thereof can be used in the treatment of breast cancer, leukemia, non-small cell lung cancer, colon cancer, melanoma, ovarian cancer, renal cancer, prostate cancer and cancer of the CNS. | 2013-06-27 |
20130165521 | TREATMENT OF FUNGAL INFECTIONS - The present disclosure relates to compositions comprising formic acid as an active ingredient and a softening agent or emollient for use in the treatment of fungal infections of the skin and/or nail(s) of mammals, as well as methods for treatment utilizing such compositions. | 2013-06-27 |
20130165522 | GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES - This invention provides a pharmaceutical composition for topical application to the skin of a patient in need of, comprising neramexane or a pharmaceutically acceptable salt thereof, and at least one gel forming agent for the treatment or prevention of inflammatory skin diseases such as impetigo contagiosa, acne, rosacea, eczema, atopic dermatitis, contact dermatitis, seborrheic dermatitis, psoriasis, and/or oily skin. The at least one gel forming agent comprises polymers with neutral and/or positively charged polymer backbones. | 2013-06-27 |
20130165523 | COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASE-ASSOCIATED BONE LOSS - The present invention concerns a method for treating and/or preventing a disease in a subject comprising the step of administrating an effective amount of a compound of formula I to a subject in need thereof. | 2013-06-27 |
20130165524 | TRANS-CLOMIPHENE FOR METABOLIC SYNDROME - The present invention relates to the administration of compositions comprising an antiestrogen, preferably trans-clomiphene, for treating metabolic syndrome in a subject. The invention is also directed to methods for reducing fasting glucose levels in a subject by administering a composition comprising an antiestrogen, preferably trans-clomiphene. | 2013-06-27 |
20130165525 | METHODS OF MAKING AND USING PRECURSOR POLYELECTROLYTE COMPLEXES - The invention relates to compositions and methods of treatment employing compositions comprising polyelectrolyte complexes. The compositions include a water-soluble first polyelectrolyte bearing a net cationic charge or capable of developing a net cationic charge and a water-soluble second polyelectrolyte bearing a net anionic charge or capable of developing a net anionic charge. The total polyelectrolyte concentration of the first solution is at least 110 millimolar. The composition is free of coacervates, precipitates, latex particles, synthetic block copolymers, silicone copolymers, cross-linked poly(acrylic) and cross-linked water-soluble polyelectrolyte. The composition may be a concentrate, to be diluted prior to use to treat a surface. | 2013-06-27 |
20130165526 | TOPICAL TREATMENT WITH DAPSONE IN G6PD-DEFICIENT PATIENTS - The present invention provides a pharmaceutical carrier system comprising a dermatological composition that is a semi-solid aqueous gel, wherein dapsone is dissolved in the gel such that the dapsone has the capacity to cross the stratum corneum layer of the epidermis, and wherein the composition also contains dapsone in a microparticulate state that does not readily cross the stratum corneum of the epidermis. The present invention also provides methods of treating dermatological conditions in G6PD-deficient patients with the composition, while avoiding adverse hematologic effects. | 2013-06-27 |
20130165527 | Method for Administering an NMDA Receptor Antagonist to a Subject - Compositions and methods for administering memantine to a subject are provided. In particular, a solid pharmaceutical composition in a unit dosage form for once daily oral administration is provided. The compositions comprises an extended release formulation of 22.5 mg to 33.75 mg memantine, or a pharmaceutically acceptable salt thereof, wherein administration of a dose of the composition to a human subject provides a mean plasma memantine concentration profile characterized by a change in memantine concentration as a function of time (dC/dT) that is less than 50% of the dC/dT provided by the same quantity of an immediate release form of memantine, determined in a time period between 0 hours to 6 hours after administration of memantine, and wherein dC/dT is measured in a single-dose human PK study. Methods of treating dementia, in particular Alzheimer's diseases, using the compositions are provided. | 2013-06-27 |
20130165528 | DISINFECTANT DETERGENT COMPOSITION - A disinfectant detergent composition containing a food or food additive as a main component is provided. The disinfectant detergent composition contains the following components (a), (b), and (c). The sum [a+b] of the component (a) content and the component (b) content of the composition ranges from 0.1% to 30% by mass, the mass ratio [a/b] of the component (a) to the component (b) ranges from 1/2 to 4/1, and the component (c) content of the composition ranges from 60% to 99.5% by mass. (a) polyoxyethylene sorbitan monolaurate (b) a fatty acid glyceride in which the number of carbon atoms of its acyl group ranges from 8 to 12, the monoglyceride content of the component (b) being 85% by mass or more, the mass fraction of 1-monoglyceride relative to the total amount of monoglycerides being in the range of 0.9 to 1.0 (c) water and/or ethanol. | 2013-06-27 |
20130165529 | PICEATANNOL-CONTAINING COMPOSITION AND METHOD OF PRODUCING PICEATANNOL-CONTAINING COMPOSITION - Provided are a piceatannol-containing composition which is a composition originating in a natural material and containing piceatannol at a high concentration, and a method of producing the piceatannol-containing composition. A piceatannol-containing composition which contains 0.0001 to 99.9% by mass of piceatannol is obtained by extracting passion fruit seeds. The extraction of piceatannol is carried out by grinding the passion fruit seeds, adding at least one solvent selected from an aqueous alcohol-based solvent and an aqueous ketone-based solvent and agitating to thereby extract piceatannol into the above-described solvent. In this case, it is preferable to conduct stepwise extraction by using both of the aqueous alcohol-based solvent and the aqueous ketone-based solvent. | 2013-06-27 |
20130165530 | FOAMABLE ALCOHOLIC COMPOSITIONS WITH SKIN BENEFITS - A non-aqueous, non-aerosol foamable composition is provided that includes at least 40 wt % alcohol, based upon the total weight of the alcoholic composition; a foaming surfactant; and a skin benefit agent selected from the group consisting of emollients, humectants, occlusive agents, and other moisturizers to provide moisturization, skin softening, skin barrier maintenance, anti-irritation, or other skin health benefits. The foamable alcoholic composition forms a stable foam when mixed with air. | 2013-06-27 |
20130165531 | Anthocyanin based colorant compositions - The invention describes novel aluminum based aqueous anthocyanin solutions, methods to prepare them and the compositions thereof. | 2013-06-27 |
20130165532 | NOVEL DECENAL MIXTURES AND THEIR USE IN PERFUME COMPOSITIONS - The present invention relates to a novel decenal mixture and the incorporation and use of this mixture as a fragrance material. The novel decenal mixture contains decenals that are represented by the formula set forth below: | 2013-06-27 |
20130165533 | METHOD FOR CROSSLINKING A COLLOID, AND CROSSLINKED COLLOID THEREFROM - The disclosure provides a method for crosslinking a colloid, including: (a) providing a colloid solution; (b) adding a crosslinking agent and solid particles to the colloid solution, wherein the amount of solid particles added is enough to convert the colloid solution into a solid mixture, and wherein a crosslinking reaction proceeds in the solid mixture; and (c) removing the solid particles from the solid mixture. | 2013-06-27 |
20130165534 | SYSTEM AND METHOD FOR PRODUCTION OF FISCHER-TROPSCH SYNTHESIS PRODUCTS AND POWER - A method for generation of power and Fischer-Tropsch synthesis products by producing synthesis gas comprising hydrogen and carbon monoxide, producing Fischer-Tropsch synthesis products and Fischer-Tropsch tailgas from a first portion of the synthesis gas, and generating power from a second portion of the synthesis gas, from at least a portion of the Fischer-Tropsch tailgas, or from both. The method may also comprise conditioning at least a portion of the synthesis gas and/or upgrading at least a portion of the Fischer-Tropsch synthesis products. A system for carrying out the method is also provided. | 2013-06-27 |
20130165535 | Methanation Of A Syngas - Systems and methods for producing a synthetic natural gas are provided. A syngas can be separated into a first syngas, a second syngas, and a third syngas. The first syngas can be methanated to produce a first effluent. The first effluent can be mixed with the second syngas to produce a first mixed effluent. The first mixed effluent can be methanated to produce a second effluent. The second mixed effluent can be methanated to produce a third effluent. The third effluent can be cooled to produce a first cooled effluent. The first cooled effluent can be cooled to produce a synthetic natural gas. | 2013-06-27 |
20130165536 | PARTIAL BOILING IN MINI AND MICRO-CHANNELS - The invention provides methods, apparatus and systems in which there is partial boiling of a liquid in a mini-channel or microchannel. The partial boiling removes heat from an exothermic process. | 2013-06-27 |
20130165537 | STACKED CATALYST BED FOR FISCHER-TROPSCH - The present invention pertains to a reactor tube comprising a fixed bed of Fischer-Tropsch catalyst particles, wherein the catalyst particles in 5% to 40% of the fixed bed volume at the upstream end have an average outer surface to volume ratio (S/V) of between 3.0 to 4.5 mm | 2013-06-27 |
20130165538 | ANIONIC EXCHANGE ELECTROLYTE POLYMER MEMBRANES - The present disclosure provides a membrane having a first major surface and a second major surface and including one or more anionic exchange electrolyte polymers. The membranes can be useful for selectively mass transporting molecules and/or ions. | 2013-06-27 |
20130165539 | ALKALINE-STABLE CHROMATOGRAPHIC RESINS - This invention is directed to the production of improved chromatographic resins and method of making and using such resins. | 2013-06-27 |
20130165540 | Porous Calcium Phospate Granules and Methods of Making and Using the Same - Porous calcium phosphate granules and methods of making the same are provided. Embodiments of the methods include producing a solid spherical granule precursor that includes: (i) a calcium phosphate component; and (ii) a porogen component; and (b) removing the porogen component from the solid spherical granule precursor to produce a spherical porous calcium phosphate granule. Granules of the invention find use in a variety of different applications. | 2013-06-27 |
20130165541 | PROCESS FOR PREPARING POROUS POLYMER PARTICLES - A process for forming polymer particles with aligned pores and controlled narrow particle size distribution, including: a) forming an oil phase by dissolving a polymeric binder in a solvent; b) dispersing the oil phase into a water phase containing a controlled amount of particulate stabilizer and forming an oil-in-water emulsion of controlled narrow dispersed oil phase droplet size distribution; c) freezing the emulsion to freeze solvent in the oil droplets to form frozen solvent domains within the polymeric binder, and also the water in the continuous water phase; and d) removing the frozen solvent from the polymeric binder and the frozen water in the continuous water phase, thereby forming porous polymer particles of controlled narrow particle size distribution and containing directional aligned non-spherical pore structures. Optionally, the porous particles may contain encapsulated functional ingredients. | 2013-06-27 |
20130165542 | GLASS BUBBLES, COMPOSITES THEREFROM, AND METHOD OF MAKING GLASS BUBBLES - The present disclosure provides a plurality of glass bubbles having an average true density of up to about 0.55 grams per cubic centimeter and a size distribution including a median size in a range from about 15 micrometers to 40 micrometers. A hydrostatic pressure at which ten percent by volume of the plurality of glass bubbles collapses is at least about 100 megapascals. In some embodiments, the plurality of glass bubbles is a graded fraction preparable by classifying a second plurality of glass bubbles, wherein the second plurality of glass bubbles has a higher percentage of glass bubbles with a size of up to ten micrometers than the first plurality of glass bubbles. Composites including the plurality of glass bubbles are also disclosed. | 2013-06-27 |
20130165543 | CONCRETE SUBSTITUTE - A concrete substitute material ( | 2013-06-27 |
20130165544 | ISOCYANATE-TERMINATED PREPOLYMER, THE METHOD FOR PREPARING THE SAME AND THE USE THEREOF - The present invention pertains to the field of polyurethane, especially relates to an isocyanate-terminated prepolymer, the method for preparing the same and the use thereof. The present invention adjusts the reaction components and the ratios thereof to obtain an isocyanate-terminated prepolymer suitable for preparing flexible polyurethane foam under a relative low mold temperature. The method for preparing flexible polyurethane foam by using the isocyanate-terminated prepolymer provided in this present invention can reduce the mold temperature, production time and energy consumption, as well as to obtain a polyurethane flexible foam processing good physical and mechanical properties. | 2013-06-27 |
20130165545 | BONDING TOGETHER RESIN NANO CERAMIC BLOCKS - First and second smaller blocks of resin nano ceramic material are bonded together to form a larger resin nano ceramic block. | 2013-06-27 |
20130165546 | X-RAY OPAQUE COATING - The disclosure relates to an X-ray opaque coating containing an epoxy resin including an iodinated phenol covalently bonded to a glycidyl ether. Iodinated phenol covalently bonded to a glycidyl ether may include iodinated bisphenol A, such as tetraiodobisphenol A, a glycidyl ether of mono-iodophenol, bis-iodephenol, tri-iodophenol, or combinations thereof. The coating may include an X-ray opaque inorganic filler. The disclosure also relates to an electronic component including a substrate and at last one device coupled to the substrate with an obfuscation layer disposed over the substrate for obscuring the device from an X-ray source. The obfuscation layer may include an X-ray opaque coating. The disclosure additionally relates to- a method of obscuring at least a portion of an electronic component by depositing an obfuscation layer that may includes m X-ray opaque coating and a method of forming an X-ray opaque coating. | 2013-06-27 |
20130165547 | POLYCARBONATE NANOCOMPOSITES - Polycarbonate nanocomposites comprising a polycarbonate matrix having non-oxidized metal nanoparticles dispersed therein are disclosed. The polycarbonate nanocomposite is produced by a process comprising forming a reaction mixture comprising a dihydroxy compound, an activated carbonate, a metal precursor, and a solvent; and in-situ polymerizing the reaction mixture to form a nanocomposite comprising a polycarbonate matrix and metal nanoparticles dispersed therein. The metal precursor comprises a metal selected from a specified group. The nanocomposites have improved mechanical, optical, electrical and/or magnetic properties. Also disclosed are articles formed from such polycarbonate nanocomposites. | 2013-06-27 |
20130165548 | SIZING COMPOSITIONS AND SIZED PRODUCTS FOR THERMOPLASTIC COMPOSITES - Sizing compositions to size fibers or particles used in plastic composites are described. The compositions may include a solution with a polymerization compound selected from: (a) at least one non-isocyanate-containing polymerization initiator (PI) for initiating the polymerization of caprolactam monomers; or (b) at least one precursor for a non-isocyanate-containing PI for initiating the polymerization of caprolactam monomers. Methods of making the sizing the composition, as well as methods of making reinforced thermoplastic composites from sized fibers or particles, are also described. | 2013-06-27 |
20130165549 | PRINTING FORM AND PROCESS FOR PREPARING THE PRINTING FORM WITH CURABLE COMPOSITION HAVING SOLVENT-FREE EPOXY RESIN - The invention pertains to a printing form and a process for preparing the printing form from a solvent-free curable composition that includes, in prescribed relative amounts, an epoxy novolac resin; a bisphenol-A epoxy resin or a bisphenol-F epoxy resin; a monofunctional reactive diluent; a multifunctional reactive diluent; and a stoichiometric amount of an amine curing agent. The ratio of the epoxy novolac resin to the bisphenol epoxy resin is 1:3 to 3:1 by weight. The process includes applying the curable composition to a supporting substrate to form a layer, curing the layer at one or more temperatures in a temperature range, and engraving to form at least one cell in the cured layer. The process prepares printing forms, particularly gravure printing forms, having a cured resin composition layer that is engravable, resistant to solvent inks and to mechanical wear, and capable of printing gravure-quality images. | 2013-06-27 |
20130165550 | COATING COMPOSITIONS EXHIBITING CORROSION RESISTANCE PROPERTIES, RELATED COATED SUBSTRATES, AND METHODS - Coating compositions are disclosed that include corrosion resisting particles such that the coating composition can exhibit corrosion resistance properties. Also disclosed are substrates at least partially coated with a coating deposited from such a composition and multi-component composite coatings, wherein at least one coating later is deposited from such a coating composition. Methods and apparatus for making ultrafine solid particles are also disclosed. | 2013-06-27 |
20130165551 | ADHESIVE RESIN COMPOSITION FOR HDD MOTOR AND HDD MOTOR FABRICATED USING THE SAME - There are provided an adhesive resin composition for a HDD motor and a HDD motor fabricated using the same. The adhesive resin composition for a HDD motor includes: 25 to 35 parts by weight of a bisphenol E-epoxy resin; 10 to 25 parts by weight of an epoxy resin; 10 to 20 parts by weight of mercaptan; and 5 to 15 parts by weight of imidazole. The constituents of an epoxy adhesive material may be controlled, such that a curing speed may be increased, as compared to the case of the related art, thereby enhancing working efficiency and reliability. | 2013-06-27 |
20130165552 | ADDITIVE FOR PERMEABLE CONCRETES WITH IMPROVED PROPERTIES AND METHOD FOR MANUFACTURING THEREOF - An additive for manufacturing permeable concretes with improved properties and method for manufacturing the same are provided. The additive comprises in a total composition: 33.70 to 54.90% water; 0.30 to 0.50% defoamer; 0.30 to 0.40% bactericide; 0.30 to 0.50% polyglycol; 7.20 to 24.00% of a combination of emulsifiers; 15.50 to 17.00% moisturizer; 0.8 to 22.90% dispersant; and 0.70 to 1.00% biopolymer. The additive for manufacturing permeable concretes can be added to any type of stony aggregate and/or cement improving the product's mechanical properties required in each step before, during, and after of the setting. | 2013-06-27 |
20130165553 | COMPACTED BODY FOR USE AS MINERAL CHARGE IN THE PRODUCTION OF MINERAL WOOL - A compacted body, in particular a briquette, suitable for use as mineral charge in the production of man-made vitreous fibres (MMVF), comprising: (i) recycled waste mineral wool which comprises MMV fibres in contact with a non-cured MMVF binder comprising: (a) a sugar component and (b) a reaction product of a polycarboxylic acid component and an amine component; and (ii) a cement binder. | 2013-06-27 |
20130165554 | Dynamic Mechanical Polymer Nanocomposites - Polymer nanocomposites exhibit a reversible change in stiffness and strength in response to a stimulus. The polymer nanocomposites include a matrix polymer with a comparably low modulus and strength and nanoparticles that have a comparably high modulus and strength. The particle-particle interactions are switched by the stimulus, to change the overall material's mechanical properties. In a preferred embodiment, a chemical regulator Is used to facilitate changes of the mechanical properties. Methods for inducing modulus changes in polymer nanocomposites are also disclosed. | 2013-06-27 |
20130165555 | AQUEOUS PAINTING MATERIAL COMPOSITION - The invention provides an aqueous painting material composition. which provides a coating film such that, after it has dried, it neither runs nor dissolves in water even if waterdrops adhere thereto, and such that it has water resistance in such a degree that, even if an extra layer of a second aqueous painting material composition is added thereon, it is not shifted, like the conventionally known emulsion paints, and further such that, even if it has adhered to a palette or a paintbrush, and dried, it can be readily washed away by washing it with water. | 2013-06-27 |
20130165556 | HIGHLY SCRATCH RESISTANT ONE-PART CLEAR COATING COMPOSITION COMPRISING SILANE-MODIFIED BLOCKED ISOCYANATE FOR CARS - The present invention relates to a highly scratch resistant one-part clear coating composition comprising a silane-modified blocked isocyanate for cars, in which a blocked isocyanate curing system comprising a silane functional group is applied besides an acrylic melamine-curing system used as a clear coat system for new cars unlike an acrylic-melamine curing clear coat used as a general clear coat for cars such that the formation of scratches on the surface of a car occurring during the automatic or manual car wash is minimized to maintain initial gloss for as long as possible, thereby maintaining the intrinsic color of the car as well as increasing a degree of consumer's satisfaction with the outer appearance of the car. | 2013-06-27 |
20130165557 | LAMINATE OF AN ACRYLIC RESIN COMPOSITION LAYER CONTAINING TRIAZINE BASED ULTRA-VIOLET COMPOUNDS AND AN ORGANOSILOXANE RESIN COMPOSITION LAYER - It is an object of the present invention to provide a laminate having excellent weatherability and abrasion resistance as well as adhesion. | 2013-06-27 |
20130165558 | LAYERED SILICATE FLAME RETARDANT COMPOSITIONS - The invention relates to flame retardant compositions that contain mixtures of melamine polyphosphates with layered silicates added to the polymer substrates, particularly polyamides. | 2013-06-27 |
20130165559 | COMPOSITION WITH ACID-ACTIVATABLE METAL COMPONENT - A composition which includes a plastic matrix, an acid-activatable metal component selected from aluminium (Al), magnesium (Mg), zinc (Zn), copper (Cu), iron (Fe), tin (Sn), cobalt (Co) and manganese (Mn); and at least one acid carrier which in the RoO test has a rate of oxidation (RoO=rate of oxidation) of less than 1000 ppm of iron with a reaction time of 60 min. | 2013-06-27 |
20130165560 | Modified Fillers And Elastomeric Composites Comprising Same - Modified fillers are described which have adsorbed and/or attached chemical groups, such as a triazole and/or pyrazole thereon. Other modified fillers are also described. Elastomeric compositions containing the modified filler are further described, as well as methods to improve hysteresis and/or abrasion resistance in elastomeric compositions using the modified fillers of the present invention. | 2013-06-27 |
20130165561 | ADHESIVE COMPOSITION FOR POLARIZING PLATE AND POLARIZING PLATE AND OPTICAL MEMBER INCLUDING ADHESIVE LAYER FORMED USING THE SAME - A polarizing plate and an optical member, the polarizing plate including an adhesive layer, the adhesive layer being prepared from an adhesive composition including a (meth)acrylic copolymer, a crosslinking agent, and a tackifier, the tackifier including an acrylic modified petroleum resin represented by Formula 1: | 2013-06-27 |
20130165562 | PHOSPHOROUS FLAME RETARDANT CONTAINING CLAY - A phosphorous flame retardant containing clay is made in two steps. First, chlorines of hexachlorocyclotriphosphazene (HCP) are substituted with poly(oxyalkylene)-amines in the replacement reaction. Layered or exfoliated clay are then added to perform the intercalation, exfoliation or adsorption reaction to produce the phosphorous flame retardant. The phosphorous flame retardant can be further mixed with a polymer to promote the flame-retarding effect of the polymer. | 2013-06-27 |
20130165563 | POLYPROPYLENE WITH LOW FLUID RETENTION - A controlled rheology polypropylene that is made from Ziegler-Natta produced random copolymer and an additive formulation, extruded in the presence of a peroxide, exhibits low fluid retention and can be used to make medical/laboratory grade equipment, such a pipette tips. | 2013-06-27 |
20130165564 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF - There is provided herein an aluminum methyl methylphosphonate in crystalline form wherein 90% of the aluminum methyl methylphoshponate has a particle size of less than 10 microns, and wherein the aluminum methyl methylphosphonate is obtained by the process of reacting aluminum hydroxide with dimethyl methylphosphonate in the presence of a catalyst. | 2013-06-27 |
20130165565 | RESIN COMPOUND, RESIN COMPOSITION, AND RESIN-MOLDED ARTICLE - A resin compound includes a reaction product of (A) polymer which is at least selected from aliphatic polyester and aliphatic polyamide and (B) an aromatic compound with a compositional ratio from 0.1 to 10 parts by weight with respect to 100 parts by weight of (A) and represented by the following Formula (1): | 2013-06-27 |
20130165566 | MIXTURES COMPRISING AMINOALKYL-CONTAINING POLYORGANOSILOXANES AND SILICONE RESINS - Storage stable polyorganosiloxane-silicone resin mixtures contain:
| 2013-06-27 |
20130165567 | MOULD-RELEASE AGENT COMBINATIONS - The present invention relates to mould-release agent combinations for plastics comprising A. at least one amide wax and B. at least one ester wax and/or C. at least one saponified wax, and also to the use of the mould-release agent combinations for plastics, where the plastic is polyamide, and also to thermoplastic moulding compositions based on polyamide comprising these mould-release agent combinations, and to processes for their production. | 2013-06-27 |
20130165568 | HOT-MELT ADHESIVE COMPOSITION INTENDED TO FORM A FILM SUITABLE FOR WRAPPING A HOT-MELT ADHESIVE PRODUCT, AND ITS USE - A hot-melt adhesive composition intended to form a film:
| 2013-06-27 |
20130165569 | Easily Removable Indoor/Outdoor Concrete Curing Compound - A water-resistant, easily removable indoor/outdoor concrete curing coating compound including water, a hydrophobic membrane-forming polymer resin, and a rosin soap or rosin soap derivative that is readily self-degrading and film-forming. | 2013-06-27 |
20130165570 | LAMINATE OF AN ACRYLIC RESIN COMPOSITION LAYER CONTAINING TRIAZINE BASED ULTRA-VIOLET COMPOUNDS AND AN ORGANOSILOXANE RESIN COMPOSITION LAYER - A laminate having excellent weatherability and abrasion resistance as well as adhesion. The laminate comprises a base, a first layer formed by thermally curing an acrylic resin composition and a second layer formed by thermally curing an organosiloxane resin composition, all of which are formed in the mentioned order, wherein the acrylic resin composition comprises:
| 2013-06-27 |
20130165571 | USE OF NUCLEATION IN ICP RESINS - A blown film composition including an impact copolymer polypropylene component and a nucleating agent, wherein the blown film has improved processing and physical properties. | 2013-06-27 |
20130165572 | PRECURSOR POLYELECTROLYTE COMPLEXES COMPOSITIONS - The invention relates to compositions and methods of treatment employing compositions comprising polyelectrolyte complexes. The compositions include a water-soluble first polyelectrolyte bearing a net cationic charge or capable of developing a net cationic charge and a water-soluble second polyelectrolyte bearing a net anionic charge or capable of developing a net anionic charge. The total polyelectrolyte concentration of the first solution is at least 110 millimolar. The composition is free of coacervates, precipitates, latex particles, synthetic block copolymers, silicone copolymers, cross-linked poly(acrylic) and cross-linked water-soluble polyelectrolyte. The composition may be a concentrate, to be diluted prior to use to treat a surface. | 2013-06-27 |
20130165573 | ORGANIC-INORGANIC COMPOSITE, MOLDED PRODUCT, AND OPTICAL ELEMENT - There are provided an organic-inorganic composite having a high refractive index and a low Abbe number in which metal oxide particles of at least one type is added to a polymer containing a repeating unit having the general formula (1) described in Claim | 2013-06-27 |
20130165574 | COATING COMPOSITION, METHOD OF PRODUCING THE SAME, ARTICLES MADE THEREFROM, AND METHOD OF MAKING SUCH ARTICLES - The process for producing the coating composition according to the instant invention comprises the steps of: ( | 2013-06-27 |
20130165575 | Artificial Marble Including Cellular Metal Chips and Method for Making the Same - An artificial marble includes an artificial marble matrix made of a thermosetting resin and metal chips having a cellular structure. The metal chips can be evenly dispersed throughout the artificial marble and can form foam or open-cell patterns. | 2013-06-27 |
20130165576 | Bracket for Protecting Liquid Crystal Display (LCD) of Portable Display Device - A bracket for protecting the liquid crystal display (LCD) of a portable display device comprises (A) a polyamide resin, and (B) a carbon fiber, wherein the ratio of (A):(B) of the (A) polyamide resin and the (B) carbon fiber is about 20 to about 40 wt %: about 60 to about 80 wt %, and the (A) polyamide resin comprises (a1) an aromatic polyamide and (a2) an aliphatic polyamide including a C | 2013-06-27 |
20130165577 | Thermoplastic Resin Composition with Flowability, Transparency, and Impact Strength - A thermoplastic resin composition includes (A) a transparent rubber modified aromatic vinyl copolymer including (a1) a graft copolymer including a core of a rubber based polymer and a shell formed on a surface of the core by graft polymerization of alkyl ester monomer, unsaturated nitrile monomer, and aromatic vinyl monomer; and (a2) a non-graft copolymer including a unit derived from an alkyl ester monomer; and (B) a low molecular weight acrylic copolymer with a weight average molecular weight of about 1,000 to about 10,000 g/mol. The thermoplastic resin composition can have a melt flow index of about 13 to about 35 g/10 min, a haze of about 2 to about 5%, and a Notch Izod impact strength of about 11 to about 15 kgf·cm/cm. | 2013-06-27 |
20130165578 | TIRE WITH RUBBER COMPONENT CONTAINING FUNCTIONALIZED POLYBUTADIENE AND FUNCTIONALIZED STYRENE/BUTADIENE ELASTOMERS - Pneumatic rubber tire with a component comprised of a silica reinforced rubber composition comprised of a combination of functionalized polybutadiene rubber and functionalized styrene/butadiene elastomer. | 2013-06-27 |
20130165579 | PNEUMATIC TIRE - The present invention is directed to a pneumatic tire having a tread, the tread comprising a rubber composition comprising:
| 2013-06-27 |
20130165580 | Sedimentation-Stabilized Water-Based Pigment Preparations - The invention relates to aqueous pigment preparations, containing (A) 1 to 75 wt % of an organic or inorganic white or colored pigment or a mixture of various organic or inorganic white or colored pigments, (B) 0.01 to 40 wt % of one or more wetting and dispersing additives, (C) 0.01 to 5 wt % of a water-soluble or water-swellable, cross-linked copolymer containing 50 to 98.99 wt % of acrylamidoalkylsulfonic acid and salts thereof of the formula (I), 1 to 49.99 wt % of cyclic N-vinylcarboxamides of the formula (II), and 0.01 to 8 wt % of a cross-linking monomer having at least 2 olefinically unsaturated units, wherein R is a hydrogen atom or a methyl group, A is a linear or branched alkylene group having 1 to 8 carbon atoms, M is a hydrogen atom, ammonium, or an alkali metal ion, and n is an integer from 2 to 9. | 2013-06-27 |
20130165581 | CROSSLINKABLE COMPOSITION AND METHOD OF PRODUCING THE SAME - The instant invention provides crosslinkable compositions, and method of producing the same. The non-aqueous single phase crosslinkable composition comprises: (a) a polyol having an average of 2 or more hydroxyl functional groups; (b) polyaldehyde, or acetal or hemiacetal thereof; and (c) an acid catalyst having pK of less than 6; and (d) optionally one or more organic solvents. | 2013-06-27 |
20130165582 | PROCESS FOR PRODUCTION OF HALOBUTYL IONOMERS - The invention relates to an energy efficient, environmentally favourable process for the preparation of butyl ionomers that uses a common medium for both solution polymerization and subsequent bromination of butyl rubber. More particularly, the invention relates to a process that employs a common aliphatic medium for both solution polymerization and bromination of butyl rubber in the presence of a brominating agent and optionally for subsequent reaction with at least one nitrogen and/or phosphorus based nucleophile. | 2013-06-27 |
20130165583 | EXTRUDABLE PRESSURE SENSITIVE ADHESIVE COMPOSITION AND METHODS FOR PREPARING THE SAME - A phase-separated polymeric composition comprising a first phase including polyurethane domains; and a second phase including a butyl rubber matrix. | 2013-06-27 |